Prosecution Insights
Last updated: October 25, 2026

Leech Tishman Fuscaldo & Lampl, LLC

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering

20 pending office actions • 16 clients • 20 examiners • 16 art units • 0 of 20 (0%) have an AI response strategy ready • 42 patents granted in the last 365 days

Analysis

Leech Tishman Fuscaldo & Lampl has 23 pending office actions in Chemistry & Materials and 2368 career applications. Its resolved allowance rate is 77.78%, with an average of 3.16 office actions per allowance.

The application volume provides a substantial base for reading the resolved allowance measure. The current pending docket represents active work, while the average-action figure shows that allowed matters generally involved multiple examination exchanges. Practitioners should treat the allowance rate as a portfolio outcome measure and review individual chemistry and materials files for the issues driving those exchanges.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=2368 apps, methodology: how we score firms)

77.8%
Allowance Rate
n=2368
+0.42σ
Allowance Rate (norm)
n=2368
3.2
OAs to Allowance
n=1225
-0.24σ
OAs to Allow (norm)
n=1225
1040 days
Time to Allowance
n=1225
+12.8pp
Interview Lift
n=2368
22.0%
RCE Rate
n=2368
2.7%
Appeal Rate
n=2368

Rejection Performance (% of received rejections ultimately overcome)

83.6%
§101 Overcome
n=110
71.7%
§102 Overcome
n=502
74.3%
§103 Overcome
n=856
77.8%
§112 Overcome
n=522

Specialization & Scale

Y10T, G01N, G06F
Top CPC Subclasses
9%
Top-3 CPC Share
n=2368
1
Practitioners
n=2368
2368.0
Apps / Practitioner
n=2368

Portfolio Summary

20
Total Pending OAs
14
Non-Final OAs
6
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

13
Hard (65%)
7
Medium (35%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only6 (30%)
Double-patenting + other1 (5%)
Multi-statute (no §101)13 (65%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

10
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
5% of docket
9
Mechanical / Eng
45% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

200 h
Manual time on pending OAs
40 h
Time saved (low, 20%)
70 h
Time saved (mid, 35%)
1.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
VAHDAT, KHADIJEH A 1 79.6% +20.0%
LYJAK, LORI LYNN 1 89.9% +8.5%
MONDESTIN, PIERRE FAUBE 1 — —
EKIERT, TERESA M 1 79.4% +3.0%
MCGRATH, ERIN E 1 60.3% +28.4%
MORILLO, JANELL COMBS 1 58.2% +26.1%
NGUYEN, THONG Q 1 67.8% +12.0%
MALLON, BRETT PETERSON 1 65.3% +26.0%
LYLE, SOPHIA YUAN 1 57.5% +56.9%
REYNOLDS, FRED H 1 32.9% +39.3%

Hard Cases (13)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18548064 APPARATUS AND METHOD FOR MARGINAL ABLATION IN TISSUE CAVITY FOWLER, DANIEL WAYNE 56d
19337355 METHOD AND DEVICE FOR ABLATING ANATOMICAL TARGETS FROM WITHIN A BLOOD VESSEL WITH IN-PROCEDURE FEEDBACK VAHDAT, KHADIJEH A —
19043228 MULTIPLE-PANEL FOLDING TRUCK BED COVERS LYJAK, LORI LYNN —
18995555 METHOD OF MANUFACTURE OF A REINFORCED PIPE MONDESTIN, PIERRE FAUBE —
18995567 BENDING MACHINE EKIERT, TERESA M —
18850158 AN ENDOVASCULAR OCCLUSION DEVICE MCGRATH, ERIN E —
18671765 AL-ZN-MG-CU ALUMINUM ALLOY EXTRUSIONS AND METHODS OF MANUFACTURE THEREOF MORILLO, JANELL COMBS —
18705967 COVER SLIP STICKING DEVICE NGUYEN, THONG Q —

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
19337355 METHOD AND DEVICE FOR ABLATING ANATOMICAL TARGETS FROM WITHIN A BLOOD VESSEL WITH IN-PROCEDURE FEEDBACK VAHDAT, KHADIJEH A —
18850158 AN ENDOVASCULAR OCCLUSION DEVICE MCGRATH, ERIN E —
18671765 AL-ZN-MG-CU ALUMINUM ALLOY EXTRUSIONS AND METHODS OF MANUFACTURE THEREOF MORILLO, JANELL COMBS —
18705967 COVER SLIP STICKING DEVICE NGUYEN, THONG Q —
18699614 A FABRICATED AUTOMATED UNMANNED AND GLOVELESS CLEANROOM PROCESSING ENCLOSURE MALLON, BRETT PETERSON —
18686848 SEALING APPARATUS LYLE, SOPHIA YUAN —
18294303 METHODS OF TREATING MALIGNANT GLIOMAS REYNOLDS, FRED H —

Client Portfolio (16 clients)

Top Art Units

Art UnitApps
37942
37252
17332
17982
36121
37711
28721
37621
16531
16581

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19337355 METHOD AND DEVICE FOR ABLATING ANATOMICAL TARGETS FROM WITHIN A BLOOD VESSEL WITH IN-PROCEDURE FEEDBACK Steer Medical, Inc. VAHDAT, KHADIJEH A 3794 §102§103§112 Final Rejection — Pending Sep 23, 2025
19043228 MULTIPLE-PANEL FOLDING TRUCK BED COVERS Diamondback Automotive Accessories, Inc. LYJAK, LORI LYNN 3612 §102§103 Non-Final OA — Pending Jan 31, 2025
18995555 METHOD OF MANUFACTURE OF A REINFORCED PIPE Odfjell Oceanwind AS MONDESTIN, PIERRE FAUBE 3725 §102§103§112 Non-Final OA — Pending Jan 16, 2025
18995567 BENDING MACHINE Odfjell Oceanwind AS EKIERT, TERESA M 3725 §102§103§112 Non-Final OA — Pending Jan 16, 2025
18850158 AN ENDOVASCULAR OCCLUSION DEVICE UNIVERSITY COLLEGE DUBLIN MCGRATH, ERIN E 3771 §102§103§112 Non-Final OA — Pending Sep 24, 2024
18671765 AL-ZN-MG-CU ALUMINUM ALLOY EXTRUSIONS AND METHODS OF MANUFACTURE THEREOF Universal Alloy Corporation MORILLO, JANELL COMBS 1733 §102§103§112 Non-Final OA — Pending May 22, 2024
18705967 COVER SLIP STICKING DEVICE Sakura Finetek Japan Co., Ltd. NGUYEN, THONG Q 2872 §103§112 Non-Final OA — Pending Apr 29, 2024
18699614 A FABRICATED AUTOMATED UNMANNED AND GLOVELESS CLEANROOM PROCESSING ENCLOSURE Pharma Integration S.r.l. MALLON, BRETT PETERSON 3762 §103 Non-Final OA — Pending Apr 09, 2024
18686848 SEALING APPARATUS Sakura Finetek Japan Co., Ltd. LYLE, SOPHIA YUAN 1653 §102§103§112 Non-Final OA — Pending Feb 26, 2024
18294303 METHODS OF TREATING MALIGNANT GLIOMAS Targepeutics, Inc. REYNOLDS, FRED H 1658 §102§103§112DP Non-Final OA — Pending Feb 01, 2024
18426137 ALUMINUM-MAGNESIUM-LITHIUM-SCANDIUM ALLOYS FOR ADDITIVE MANUFACTURING Srl Holding Company Pty Ltd. KESSLER, CHRISTOPHER S 1759 §102§103 Non-Final OA — Pending Jan 29, 2024
18291849 SEALING APPARATUS Sakura Finetek Japan Co., Ltd. GZYBOWSKI, MICHAEL STANLEY 1798 §103 Non-Final OA — Pending Jan 24, 2024
18561439 RECOMBINANT HOSTS COMPRISING FERRITIN OR HOMOLOGUES THEREOF Sidero Bioscience, LLC GIBBS, TERRA C 1635 §103§112 Non-Final OA — Pending Nov 16, 2023
18548064 APPARATUS AND METHOD FOR MARGINAL ABLATION IN TISSUE CAVITY Senoguard, Inc. FOWLER, DANIEL WAYNE 3794 §103§112 Final Rejection 56d Pending Aug 25, 2023
18076982 MULTI-STAGE CONVERTIBLE CRIB Bexco Enterprises, Inc. ORTIZ, ADAM C 3673 §103 Final Rejection 67d overdue Pending Dec 07, 2022
17993700 PROCESS FOR MANUFACTURING HIGH STRENGTH STEEL United States Steel Corporation WU, JENNY R 1733 §103 Final Rejection — Pending Nov 23, 2022
17971542 TRIBUTYRIN SUPPLEMENTATION PROVIDES BENEFITS FOR MENTAL WELLNESS, IMMUNE HEALTH AND FAT METABOLISM Pharmavite LLC NOTTINGHAM, KYLE GREGORY 1621 §103§112 Non-Final OA — Pending Oct 21, 2022
17795667 MEMBRANE SEALING FOR A PHYSIOLOGICAL SENSOR Sensocure AS TURK, NEIL N 1798 §103§112 Final Rejection — Pending Jul 27, 2022
17012009 OIL-IN-WATER EMULSION GUMMY COMPOSITION Pharmavite LLC BOECKELMAN, JACOB A 1655 §103 Final Rejection 190d overdue Pending Sep 03, 2020
16516762 Split Grommets For Curtains Decolin Inc. MASSAD, ABE L 3634 §103 Non-Final OA 72d overdue Pending Jul 19, 2019

Managing Leech Tishman Fuscaldo & Lampl, LLC's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Leech Tishman Fuscaldo & Lampl, LLC's patent allowance rate?

77.8% of resolved applications prosecuted by Leech Tishman Fuscaldo & Lampl, LLC were allowed, across 2,368 applications in USPTO records.

How many office actions does Leech Tishman Fuscaldo & Lampl, LLC average before allowance?

3.16 office actions per allowed application on average.

How many pending office actions does Leech Tishman Fuscaldo & Lampl, LLC have?

20 pending office actions as of October 2026, for 16 clients, before 20 examiners in 16 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month